WELLESLEY, MA--(Marketwired - December 08, 2015) - Allurion Technologies announced today that its Elipse™ Gastric Balloon has received a CE mark allowing sale of the product in the European Union.

NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, a pioneering leader in the development of innovative, scalable and trusted weight loss experiences, today announced new clinical data on the ...

NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, an established leader in the development of innovative, proven, and trusted weight loss experiences, today announced the Premarket Approval (PMA) ...

When Shantanu Gaur and Samuel Levy were students at Harvard Medical School, they noticed a striking similarity among their patients. For those who struggled with weight, many weren't satisfied with ...

New research shows Allurion Technologies’ Elipse balloon is a safe and effective procedureless weight-loss treatment, according to Science Daily. Researchers presented the data at the European Obesity ...

Allurion, a Boston-based startup offering a non-invasive gastric balloon by swallowing a pill, has gained $27 million in Series C funding from previous investor Romulus Capital, with new participation ...

NATICK – Allurion Technologies, maker of the world's only gastric balloon for weight loss that doesn't involve surgery, is shooting to become a $10 billion company, according to co-founder Dr.

Allurion Technologies’ Elipse Gastric Balloon has received a CE Mark allowing sale of the product in the European Union, according to a Med Device Online report. 1. Elipse is the world’s first ...

Allurion Technologies is hoping to be able to get FDA approval to launch its obesity treatment balloon in 2020. The Natick, MA-based company said it was making progress toward its goal of getting ...